16 / 78
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 30, No 1, January/February 2019
14
AFRICA
10
(2):165–193.
13. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD,
Levine RA,
et al
. Recommendations for evaluation of the severity of
native valvular regurgitation with two-dimensional and Doppler echo-
cardiography.
J Am Soc Echocardiogr
2003;
16
(7): 777–802.
14. Karaye KM, Saidu H, Bala MS, Yahaya IA. Prevalence, clinical charac-
teristics and outcome of pulmonary hypertension among admitted heart
failure patients.
Ann Afr Med
2013;
12
(4): 197–204.
15. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R,
et al
.
Independent and additive prognostic value of right ventricular systolic
function and pulmonary artery pressure in patients with chronic heart
failure.
J Am Coll Cardiol
2001;
37
(1): 183–188.
16. Butler J, Chomsky DB, Wilson JR. Pulmonary hypertension and exer-
cise intolerance in patients with heart failure.
J Am Coll Cardiol
1999;
34
(6): 1802–1806.
17. Merlos P, Núñez J, Sanchis J, Miñana G, Palau P, Bodí V,
et al.
Echocardiographic estimation of pulmonary arterial systolic pressure
in acute heart failure. Prognostic implications.
Eur J Intern Med
2013;
24
(6): 562–567.
18. Ghio S, Temporelli PL, Klersy C, Simioniuc A, Girardi B, Scelsi L,
et
al
. Prognostic relevance of a non-invasive evaluation of right ventricular
function and pulmonary artery pressure in patients with chronic heart
failure.
Eur J Heart Fail
2013;
15
(4): 408–414.
19. Grigioni F, Potena L, Galiè N, Fallani F, Bigliardi M, Coccolo F,
et
al
. Prognostic implications of serial assessments of pulmonary hyper-
tension in severe chronic heart failure.
J Heart Lung Transplant
2006;
25
(10): 1241–1246.
20. Leung CC, Moondra V, Catherwood E, Andrus BW. Prevalence and risk
factors of pulmonary hypertension in patients with elevated pulmonary
venous pressure and preserved ejection fraction.
Am J Cardiol
2010;
106
(2): 284–286.
21. Khush KK, Tasissa G, Butler J, McGlothlin D, De Marco T. Effect of
pulmonary hypertension on clinical outcomes in advanced heart fail-
ure: analysis of the Evaluation Study of Congestive Heart Failure and
Pulmonary Artery Catheterization Effectiveness (ESCAPE) database.
Am Heart J
2009;
157
(6): 1026–1034.
22. Amadi VN, Ajayi OE, Akintomide AO, Abiodun OO, Bamikole OJ,
Balogun MO. Pulmonary Hypertension in heart failure patients present-
ing at OAUTHC, Ile-Ife, Nigeria.
Clin Med Insights Cardiol
2016;
10
:
187–193.
23. Shah R, Gayat E, Januzzi JL, Sato N, Cohen-Solal A, diSomma S,
et al
.
Body mass index and mortality in acutely decompensated heart failure
across the world: a global obesity paradox.
J Am Coll Cardiol
2014;
63
(8): 778–785.
24. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ,
et al.
Hormonal changes and catabolic/anabolic imbalance in chronic
heart failure and their importance for cardiac cachexia.
Circulation
1997;
96
(2): 526–534.
25. McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical correlates
and reference intervals for pulmonary artery systolic pressure among
echocardiographically normal subjects.
Circulation
2001;
104
(23): 2797–
2802.
26. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH,
et
al
. 2013 ACCF/AHA guideline for the management of heart failure: a
report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol
2013;
62
(16): e147–239.
27. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS,
et al.
2016 ESC guidelines for the diagnosis and treatment of acute and
chronic heart failure: The Task Force for the diagnosis and treatment of
acute and chronic heart failure of the European Society of Cardiology
(ESC). Developed with the special contribution of the Heart Failure
Association (HFA) of the ESC.
Eur J Heart Fail
2016;
18
(8): 891–975.
28. Pinamonti B, Di Lenarda A, Sinagra G, Camerini F. Restrictive
left ventricular filling pattern in dilated cardiomyopathy assessed by
Doppler echocardiography: clinical, echocardiographic and hemody-
namic correlations and prognostic implications. Heart Muscle Disease
Study Group.
J Am Coll Cardiol
1993;
22
(3): 808–815.
29. Patel H, Desai M, Tuzcu EM, Griffin B, Kapadia S. Pulmonary hyper-
tension in mitral regurgitation.
J Am Heart Assoc
2014;
3
(4): e000748.
30. Miller WL, Grill DE, Borlaug BA. Clinical features, hemodynamics,
and outcomes of pulmonary hypertension due to chronic heart failure
with reduced ejection fraction: pulmonary hypertension and heart fail-
ure.
J Am Coll Cardiol Heart Fail
2013;
1
(4): 290–299.
31. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular
function in cardiovascular disease, part I: Anatomy, physiology, aging,
and functional assessment of the right ventricle.
Circulation
2008;
117
(11): 1436–1448.